Rus Eng
Main / Company's news / Geropharm became an expert at the plenary session of international forum IPHEB

Geropharm became an expert at the plenary session of international forum IPHEB

30 April 2012

At the end of April, Saint Petersburg hosted the second international forum on pharmaceutics and biotechnology IPhEB 2012. The event was supported by the Ministry of Industry and Trade of the Russian Federation, the Chamber of Commerce of the Russian Federation, the Plenipotentiary Representative of President of the Russian Federation in the Northwest Federal District, the administration of Saint Petersburg.

First time organized in 2011, the Forum had established itself as one of the greatest events in the field of science and technology. High technologies, development of innovative medicines now constitute a perspective area of pharmaceuticals, which leads to high interest to the event by both business and government.

Event was attended by over 1,000 participants, including representatives of government authorities, major universities and research centres of the country, industry experts, top management of pharmaceutical companies from 15 countries worldwide.

Petr Rodionov, the Director of Geropharm was one of the attendants at the plenary session National Priorities for Pharmaceutical Industry Development. Plenary session was opened by Georgiy Poltavchenko, the Governor of Saint Petersburg. In addition, the event was attended by Sergei Tsyb, the Director at the Department of Chemical and Technology Complex and Bioengineering Technologies of the Ministry of Industry and Trade of the Russian Federation; Elena Telnova, the Deputy Head of the Federal Service on Surveillance in Healthcare, Aleksandr Belyaev, the Head of the Federal Antimonopoly Service in Saint Petersburg.

Straight-through theme of the meeting was summarising subtotals of pharmaceutical cluster of Saint Petersburg under the federal target program Development of the Pharmaceutical and Medical Industry of the Russian Federation until 2020 and the further prospect. In this regard, Petr Rodionov described the activities of Geropharm within a cluster, focusing on the project of the company’s modern R&D centre already implemented in a special economic zone Neudorf. Mr. Rodionov also spoke about current status of plants construction, which is currently underway in the Pushkinskaya industrial zone (Saint Petersburg) and the Moscow Region.

During plenary session, the participants discussed main challenges that manufacturers of pharmaceuticals face today. In particular, the questions on the need to improve legislation in the sphere of state order and introduction GMP standards into manufacturing practice in Russia were touched on. As it was noted by the director of Geropharm, the system of medicinal preparation registration needs further development, since it will greatly facilitate products launch by the manufacturers, and, therefore, will contribute to successful implementation of tasks within the strategy Pharma-2020.

In parallel with the forum’s business program, the exhibition of the latest developments, products and services in medical, pharmaceutical and biotechnology industries was conducted. A separate exhibition was dedicated to the pharmaceutical cluster of Saint Petersburg, in which the exhibition stand of Geropharm was represented.

You are a health care professional?

Go up